Overview

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Trial to evaluate the dose response of SCH 527123 in reducing inflammation from an ozone-induced sputum neutrophilia in both healthy subjects and subjects with COPD.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.